Nuvectis Total Liab vs Total Assets Analysis
| NVCT Stock | USD 5.04 0.24 4.55% |
Nuvectis Pharma financial indicator trend analysis is infinitely more than just investigating Nuvectis Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nuvectis Pharma is a good investment. Please check the relationship between Nuvectis Pharma Total Liab and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.
Total Liab vs Total Assets
Total Liab vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nuvectis Pharma Total Liab account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Nuvectis Pharma's Total Liab and Total Assets is 0.43. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Assets in the same time period over historical financial statements of Nuvectis Pharma, assuming nothing else is changed. The correlation between historical values of Nuvectis Pharma's Total Liab and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Nuvectis Pharma are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Liab i.e., Nuvectis Pharma's Total Liab and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.43 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Total Assets
Total assets refers to the total amount of Nuvectis Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nuvectis Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Nuvectis Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nuvectis Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.Enterprise Value is likely to gain to about 116.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.6 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Income | 4K | 149K | 475K | 498.8K | Net Interest Income | 4K | 149K | 475K | 498.8K |
Nuvectis Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Nuvectis Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.